WealthCare Asset Management’s Pfizer PFE Stock Holding History

WealthCare Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Buy	+10,068	New	+$263K	0.1%	72

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WealthCare Asset Management's PFE Position: Q2 2026 in Review

WealthCare Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 10,068 shares worth $242K. The stake represents 0.1% of the portfolio and ranks #72 among its holdings.

2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

WealthCare Asset Management held 10,068 shares of Pfizer worth $242K as of Q2 2026.
Pfizer was a new WealthCare Asset Management position in Q2 2026.
Pfizer made up 0.1% of WealthCare Asset Management's portfolio in Q2 2026, its #72 holding.
2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WealthCare Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.